70
Views
12
CrossRef citations to date
0
Altmetric
Original Research

O-GlcNAcylation Enhances NUSAP1 Stability and Promotes Bladder Cancer Aggressiveness

, ORCID Icon, ORCID Icon, , ORCID Icon, & ORCID Icon show all
Pages 445-454 | Published online: 15 Jan 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Yaotian Hu, Zhiyi Xue, Chen Qiu, Zichao Feng, Qichao Qi, Jiwei Wang, Wenxing Jin, Zhaoyang Zhong, Xiaofei Liu, Wenjie Li, Qing Zhang, Bin Huang, Anjing Chen, Jian Wang, Ning Yang & Wenjing Zhou. (2022) Knockdown of NUSAP1 inhibits cell proliferation and invasion through downregulation of TOP2A in human glioblastoma. Cell Cycle 21:17, pages 1842-1855.
Read now

Articles from other publishers (11)

Xue-Fen He, Xiaoli Hu, Gao-Jing Wen, Zhiwei Wang & Wen-Jing Lin. (2023) O-GlcNAcylation in cancer development and immunotherapy. Cancer Letters 566, pages 216258.
Crossref
Ping Sang, Xuepeng Li & Ziyu Wang. (2023) Silver Nanoparticles Promote the Osteogenic Differentiation of Human Bone Marrow Mesenchymal Stem Cells by Modulating the O-GlcNAcylation of RUNX1. Journal of Biomedical Nanotechnology 19:5, pages 718-726.
Crossref
Magdalena Wilczak, Magdalena Surman & Małgorzata Przybyło. (2023) Altered Glycosylation in Progression and Management of Bladder Cancer. Molecules 28:8, pages 3436.
Crossref
Xinfang Qin, Jie Shi, Xia Li, Mingming Lu, Yating Zhu, Qiyuan Yang, Zhimeng Wu & Cheng Lu. (2023) Optimizing the binding of OGT and a peptidic substrate towards pseudo-substrate inhibitors via molecular dynamic simulations. Systems Microbiology and Biomanufacturing.
Crossref
Andrea Conte, Valeria Valente, Simona Paladino & Giovanna Maria Pierantoni. (2023) HIPK2 in cancer biology and therapy: Recent findings and future perspectives. Cellular Signalling 101, pages 110491.
Crossref
Qingsong Lu, Xiaozhen Zhang, Tingbo Liang & Xueli Bai. (2022) O-GlcNAcylation: an important post-translational modification and a potential therapeutic target for cancer therapy. Molecular Medicine 28:1.
Crossref
Dongdong Yang, Haiying Liu, Yongping Cai, Kangyang Lu, Xiuying Zhong, Songge Xing, Wei Song, Yaping Zhang, Ling Ye, Xia Zhu, Ting Wang, Pinggen Zhang, Shi-Ting Li, Jiaqian Feng, Weidong Jia, Huafeng Zhang & Ping Gao. (2022) Branched-chain amino acid catabolism breaks glutamine addiction to sustain hepatocellular carcinoma progression. Cell Reports 41:8, pages 111691.
Crossref
Senhan Xu, Ming Tong, Suttipong Suttapitugsakul & Ronghu Wu. (2022) Spatial and temporal proteomics reveals the distinct distributions and dynamics of O-GlcNAcylated proteins. Cell Reports 39:11, pages 110946.
Crossref
Hye Lee, Mi Kang, Young-Ju Kwon, Sama Abdi Nansa, Eui Jung, Sung Kim, Sang-Jin Lee, Kyung-Chae Jeong, Youngwook Kim, Heesun Cheong & Ho Seo. (2022) Targeted Inhibition of O-Linked β-N-Acetylglucosamine Transferase as a Promising Therapeutic Strategy to Restore Chemosensitivity and Attenuate Aggressive Tumor Traits in Chemoresistant Urothelial Carcinoma of the Bladder. Biomedicines 10:5, pages 1162.
Crossref
Liqiong Chen, Yueliang Li, Shuxian Zeng, Shujuan Duan, Zhuanglin Huang & Yi Liang. (2022) The interaction of O-GlcNAc-modified NLRX1 and IKK-α modulates IL-1β expression in M1 macrophages. In Vitro Cellular & Developmental Biology - Animal 58:5, pages 408-418.
Crossref
Lorela Ciraku, Emily M. Esquea & Mauricio J. Reginato. (2022) O-GlcNAcylation regulation of cellular signaling in cancer. Cellular Signalling 90, pages 110201.
Crossref